The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(4-methylpiperazine-1-carbonyl)phenethylamino)quinazoline-6-carbonitrile ID: ALA4875632
PubChem CID: 71679494
Max Phase: Preclinical
Molecular Formula: C23H24N6O
Molecular Weight: 400.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C(=O)c2ccc(CCNc3ncnc4ccc(C#N)cc34)cc2)CC1
Standard InChI: InChI=1S/C23H24N6O/c1-28-10-12-29(13-11-28)23(30)19-5-2-17(3-6-19)8-9-25-22-20-14-18(15-24)4-7-21(20)26-16-27-22/h2-7,14,16H,8-13H2,1H3,(H,25,26,27)
Standard InChI Key: LRSAOBXYBYKPOO-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
18.1832 -17.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1820 -18.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8901 -18.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8883 -16.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5969 -17.2977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5957 -18.1183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3019 -18.5274 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0138 -18.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0150 -17.2997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3042 -16.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4759 -16.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7681 -16.4849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3043 -16.0689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0120 -15.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0120 -14.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7197 -14.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4244 -14.8472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1316 -14.4393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1321 -13.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4194 -13.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7151 -13.6230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8393 -13.2117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5475 -13.6194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8382 -12.3945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5435 -14.4335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2476 -14.8411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9572 -14.4351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9581 -13.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2494 -13.2048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6639 -14.8454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
11 12 3 0
1 11 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
23 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
27 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 400.49Molecular Weight (Monoisotopic): 400.2012AlogP: 2.54#Rotatable Bonds: 5Polar Surface Area: 85.15Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.88CX LogP: 2.51CX LogD: 2.39Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.71Np Likeness Score: -1.57
References 1. (2019) Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventive methods for cancer,